<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46939">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01953627</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00757-36</org_study_id>
    <secondary_id>2012-21</secondary_id>
    <nct_id>NCT01953627</nct_id>
  </id_info>
  <brief_title>Laparoscopic Gynecologic Surgery With Robotic Assistance System Kymerax® : Pilot Study</brief_title>
  <official_title>Laparoscopic Gynecologic Surgery With Robotic Assistance System Kymerax® : Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic robotic surgery  (LSM) seems to increase quality of surgery. Diffusion of LSM
      is limited by cots of the only available system today. Kymerax® is a cheaper new system of
      LSM.

      Aim : To evaluate feasibility of laparoscopy with Kymerax® system in different laparoscopic
      procedures in gynecology.

      Material and methods : Observational study. Inclusion criteria were : patient requiring
      laparoscopic procedure in gynecology who give informed consent. The investigators evaluate
      procedures routinely performed by laparoscopy in gynecology.

      Hypothesis : Procedures performed routinely in gynecology were feasible with Kymerax®
      system.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>assessment of Kymerax systemerax</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Gynecological Surgery</condition>
  <arm_group>
    <arm_group_label>Surgical procedure with the system Kymerax</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical procedure with the system Kymerax</intervention_name>
    <arm_group_label>Surgical procedure with the system Kymerax</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The system Kymerax</intervention_name>
    <arm_group_label>Surgical procedure with the system Kymerax</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient requiring a following surgical procedure realized usually by coelioscopy:

        Total hysterectomy or inter annexielle for mild or neoplastic pathology Promontofixation
        for genital prolapse Annexectomie or ovarian kystectomie for ovarian pathology Pelvic or
        lombo-aortic cleaning out for uterine cancer Tubaire Salpingectomie for pathology
        Rectovaginale partition Exérèse hurts of endometriosis

        Exclusion Criteria:

          -  Patient refusing to participate in the study

          -  Patient understanding French.

          -  Minor waits
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BERNARD BELAIGUES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>aubert AGOSTINI</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP HM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>aubert AGOSTINI</last_name>
    <email>aubert.agostini@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>AUBERT AGOSTINI</last_name>
      <email>aubert.agostini@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 30, 2013</lastchanged_date>
  <firstreceived_date>September 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
